| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1152/AJPCELL.2001.280.6.C1358 |
| P698 | PubMed publication ID | 11350730 |
| P2093 | author name string | Ferrara N | |
| P433 | issue | 6 | |
| P921 | main subject | endothelium | Q111140 |
| angiogenesis | Q539568 | ||
| P304 | page(s) | C1358-66 | |
| P577 | publication date | 2001-06-01 | |
| P1433 | published in | American Journal of Physiology - Cell Physiology | Q2227080 |
| P1476 | title | Role of vascular endothelial growth factor in regulation of physiological angiogenesis | |
| P478 | volume | 280 |
| Q77742102 | 1H, 13C, and 15N resonance assignment of the vascular endothelial growth factor receptor-binding domain in complex with a receptor-blocking peptide |
| Q28508534 | A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development |
| Q33715042 | A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment |
| Q37317459 | A systematic meta-analysis of genetic association studies for diabetic retinopathy |
| Q28201376 | ADAMTS1/METH1 Inhibits Endothelial Cell Proliferation by Direct Binding and Sequestration of VEGF165 |
| Q39968868 | Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma |
| Q24810899 | Adenosine infusion increases plasma levels of VEGF in humans |
| Q44741128 | Adenovirus-mediated transfer of a minigene expressing multiple isoforms of VEGF is more effective at inducing angiogenesis than comparable vectors expressing individual VEGF cDNAs |
| Q40656016 | Adenovirus‐mediated VEGF‐A gene transfer induces bone formationin vivo |
| Q80359553 | Age-related changes in cardiac expression of VEGF and its angiogenic receptor KDR in stroke-prone spontaneously hypertensive rats |
| Q37400597 | An Elevated Maternal Plasma Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio at Midtrimester Is a Useful Predictor for Preeclampsia |
| Q24793121 | Analysis of VEGF-responsive genes involved in the activation of endothelial cells |
| Q39286115 | Angiodysplasia in von Willebrand Disease: Understanding the Clinical and Basic Science |
| Q89250918 | Angiogenesis and Hepatic Fibrosis: Western and Chinese Medicine Therapies on the Road |
| Q35380959 | Angiogenesis and melanoma - from basic science to clinical trials. |
| Q35038768 | Angiogenesis as a target for cancer therapy |
| Q35153884 | Angiogenesis in diabetes and obesity |
| Q74443495 | Angiogenesis in rheumatoid arthritis |
| Q35521647 | Angiogenesis: a curse or cure? |
| Q34037478 | Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo |
| Q54749829 | Angiostatin antagonizes the action of VEGF-A in human endothelial cells via two distinct pathways |
| Q37738212 | Anti-VEGF therapies and blood pressure: more than meets the eye. |
| Q36379513 | Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy |
| Q24812333 | Anti-lipid phosphate phosphohydrolase-3 (LPP3) antibody inhibits bFGF- and VEGF-induced capillary morphogenesis of endothelial cells |
| Q38816061 | Anti-tumor effect of bevacizumab on a xenograft model of feline mammary carcinoma |
| Q98623744 | ApoC1 promotes the metastasis of clear cell renal cell carcinoma via activation of STAT3 |
| Q33694048 | Association of Egr3 genetic polymorphisms and coronary artery disease in the Uygur and Han of China |
| Q90101191 | Association of Maternal Preeclampsia with Neonatal Respiratory Distress Syndrome in Very-Low-Birth-Weight Infants |
| Q37121685 | Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100. |
| Q37731321 | Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey |
| Q34420565 | Benefits of pre-, pro- and Syn-biotics for lung angiogenesis in malnutritional rats exposed to intermittent hypoxia. |
| Q45254492 | Better vascular engraftment and function in pancreatic islets transplanted without prior culture |
| Q33867266 | Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma |
| Q57093159 | Biodistribution and Internal Radiation Dosimetry of Tc-IDA-D-[c(RGDfK)] (BIK-505), a Novel SPECT Radiotracer for the Imaging of Integrin αβ Expression |
| Q34695003 | Biomarkers for anti-angiogenic therapy in cancer. |
| Q38169142 | Biomarkers in diabetic retinopathy and the therapeutic implications |
| Q37654773 | Biomarkers of angiogenesis and their role in the development of VEGF inhibitors |
| Q50062366 | Blood coagulation parameters after intravitreal injection of aflibercept in patients with neovascular age-related macular degeneration. |
| Q61444793 | C/EBPβ regulates Vegf gene expression in granulosa cells undergoing luteinization during ovulation in female rats |
| Q36451899 | Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging |
| Q92433295 | Cancer Therapy-Related Cardiac Dysfunction: An Overview for the Clinician |
| Q35748879 | Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia |
| Q54692515 | Characterization of vascular endothelial growth factor (VEGF) in the uterine cervix over pregnancy: effects of denervation and implications for cervical ripening. |
| Q37252297 | Characterization of vascular endothelial growth factor receptors on the endothelial cell surface during hypoxia using whole cell binding arrays |
| Q92773936 | Circular RNA expression profiling of granulosa cells in women of reproductive age with polycystic ovary syndrome |
| Q36148518 | Circulating anti-angiogenic factors during hypertensive pregnancy and increased risk of respiratory distress syndrome in preterm neonates |
| Q80688368 | Clinical update: new treatments for age-related macular degeneration |
| Q47659314 | Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease |
| Q93360910 | Collagen-based sponge hastens wound healing via decrease of inflammatory cytokines |
| Q41628071 | Combination scaffolds of salmon fibrin, hyaluronic acid, and laminin for human neural stem cell and vascular tissue engineering |
| Q34128496 | Combined vascular endothelial growth factor-A and fibroblast growth factor 4 gene transfer improves wound healing in diabetic mice |
| Q42572957 | Comparing histological, vascular and molecular responses associated with woven and lamellar bone formation induced by mechanical loading in the rat ulna |
| Q64099363 | Comparison of Mean VEGF-A Expression Between Acute Ischemic Stroke Patients and Non-Ischemic Stroke Subjects |
| Q37332402 | Compartmentalizing VEGF-induced ERK2/1 signaling in placental artery endothelial cell caveolae: a paradoxical role of caveolin-1 in placental angiogenesis in vitro |
| Q52043546 | Connexin43 deficiency causes dysregulation of coronary vasculogenesis. |
| Q59064164 | Creating unique blood vessels |
| Q37638010 | Curcumin binds tubulin, induces mitotic catastrophe, and impedes normal endothelial cell proliferation |
| Q36891037 | Current knowledge on the neuroprotective and neuroregenerative properties of citicoline in acute ischemic stroke |
| Q37057390 | Current status of signal transduction modulators in the treatment of gynecologic malignancies |
| Q43457206 | Cytoglobin may be involved in the healing process of gastric mucosal injuries in the late phase without angiogenesis |
| Q36923297 | Damaging fatigue loading stimulates increases in periosteal vascularity at sites of bone formation in the rat ulna |
| Q37067054 | Delineation of VEGF-regulated genes and functions in the cervix of pregnant rodents by DNA microarray analysis |
| Q30484062 | Determination of hierarchical relationship of Src and Rac at subcellular locations with FRET biosensors. |
| Q24302190 | Development of a highly-potent anti-angiogenic VEGF8-109 heterodimer by directed blocking of its VEGFR-2 binding site |
| Q39016518 | Differential gene expression of human chondrocytes cultured under short-term altered gravity conditions during parabolic flight maneuvers. |
| Q34092503 | Direct sensing of endothelial oxidants by vascular endothelial growth factor receptor-2 and c-Src |
| Q33803966 | Down-regulation of vascular endothelial growth factor expression by anti-Her2/neu single chain antibodies. |
| Q36747223 | Drug insight: VEGF as a therapeutic target for breast cancer |
| Q33305306 | Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. |
| Q84476768 | Effect of intensive insulin therapy on macular biometrics, plasma VEGF and its soluble receptor in newly diagnosed diabetic patients |
| Q45986058 | Effect of raloxifene on vascular endothelial growth factor expression in breast carcinomas of postmenopausal women. |
| Q47235263 | Effects and Mechanisms of Total Flavonoids from Blumea balsamifera (L.) DC. on Skin Wound in Rats |
| Q35173690 | Effects of nerve growth factor (NGF) on blood vessels area and expression of the angiogenic factors VEGF and TGFbeta1 in the rat ovary |
| Q53103069 | Effects of prolonged ingestion of epigallocatechin gallate on diabetes type 1-induced vascular modifications in the erectile tissue of rats. |
| Q34668740 | Effects of tetrahydrocurcumin on hypoxia-inducible factor-1α and vascular endothelial growth factor expression in cervical cancer cell-induced angiogenesis in nude mice. |
| Q38726751 | Effects of vascular formation during alveolar bone process morphogenesis in mice. |
| Q55048482 | Egr-1 increases angiogenesis in cartilage via binding Netrin-1 receptor DCC promoter. |
| Q84959547 | Endothelial progenitor cells are associated with response to chemotherapy in human non-small-cell lung cancer |
| Q37037548 | Energy restriction and exercise modulate angiopoietins and vascular endothelial growth factor expression in the cavernous tissue of high-fat diet-fed rats |
| Q40408299 | Enforced expression of KDR receptor promotes proliferation, survival and megakaryocytic differentiation of TF1 progenitor cell line. |
| Q33578948 | Enforced physical inactivity increases endothelial microparticle levels in healthy volunteers |
| Q37686574 | Enhanced trophic factor secretion by mesenchymal stem/stromal cells with Glycine-Histidine-Lysine (GHK)-modified alginate hydrogels |
| Q35789271 | Esophageal ulceration triggers expression of hypoxia-inducible factor-1 alpha and activates vascular endothelial growth factor gene: implications for angiogenesis and ulcer healing |
| Q28592520 | Essential requirement of CCAAT/enhancer binding proteins in embryogenesis |
| Q40718233 | Every allograft needs a silver lining. |
| Q50061599 | Exercise Training Restores the Cardiac Microrna-16 Levels Preventing Microvascular Rarefaction in Obese Zucker Rats. |
| Q73669989 | Exercise-induced expression of vascular endothelial growth factor mRNA in rat skeletal muscle is dependent on fibre type |
| Q92674148 | Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work |
| Q35250134 | Exposure to ethanol during the last trimester of pregnancy alters the maturation and immunity of the fetal lung |
| Q36084263 | Expression and Function of Hypoxia Inducible Factor-1α and Vascular Endothelial Growth Factor in Pulp Tissue of Teeth under Orthodontic Movement |
| Q39032252 | Expression and Processing of Amyloid Precursor Protein in Vascular Endothelium |
| Q33454185 | Expression of angiogenesis-related genes in the cellular component of the blood of preeclamptic women. |
| Q41943468 | Expression of hypoxia-inducible factor-1alpha and the protein products of its target genes in diabetic fibrovascular epiretinal membranes |
| Q24797535 | Expression of the pro-angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 by human breast carcinomas is responsive to nutrient deprivation and endoplasmic reticulum stress |
| Q36261872 | Expression of vascular endothelial growth factor (VEGF) under hypoxia in placenta with intrahepatic cholestasis of pregnancy and its clinically pathological significance |
| Q41849120 | Extracellular ATP May Contribute to Tissue Repair by Rapidly Stimulating Purinergic Receptor X7-Dependent Vascular Endothelial Growth Factor Release from Primary Human Monocytes |
| Q45771543 | Extraordinary response of metastatic pancreatic cancer to apatinib after failed chemotherapy: A case report and literature review |
| Q33816926 | FLT1 genetic variation predisposes to neovascular AMD in ethnically diverse populations and alters systemic FLT1 expression |
| Q44296497 | Fatty acid mobilized by the vascular endothelial growth factor in human endothelial cells |
| Q36408032 | Fluid pressure is a magnitude-dependent modulator of early endothelial tubulogenic activity: implications related to a potential tissue-engineering control parameter |
| Q42446877 | Focal adhesion kinase mediates porcine venular hyperpermeability elicited by vascular endothelial growth factor |
| Q44350350 | Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes |
| Q35218706 | Gene-based therapeutic angiogenesis |
| Q35748149 | Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma. |
| Q39740133 | Getting Tie(2)d up in angiogenesis |
| Q48277406 | Glioma-associated endothelial cells show evidence of replicative senescence |
| Q35568152 | Growing and shaping the vascular tree: multiple roles for VEGF |
| Q24669693 | Gut mucosal healing: is the science relevant? |
| Q41880629 | Heparinized collagen scaffolds with and without growth factors for the repair of diaphragmatic hernia: construction and in vivo evaluation. |
| Q43894681 | Herpes simplex virus amplicon delivery of a hypoxia-inducible angiogenic inhibitor blocks capillary formation in hepatocellular carcinoma |
| Q45924805 | High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection. |
| Q53367067 | High pKDR immunohistochemical expression is an unfavourable prognostic biomarker in patients with advanced colorectal cancer treated with chemotherapy plus bevacizumab. |
| Q33677926 | Higher expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) and metalloproteinase-9 (MMP-9) in a rat model of peritoneal endometriosis is similar to cancer diseases |
| Q41877512 | Hypoxia-induced expression of VEGF splice variants and protein in four retinal cell types. |
| Q37236104 | Hypoxia-ischemia and retinal ganglion cell damage |
| Q45711455 | Identification of functional VEGF receptors on human platelets |
| Q42602933 | Imaging of Integrin αvβ3 Expression in Lung Cancers and Brain Tumors Using Single-Photon Emission Computed Tomography with a Novel Radiotracer 99mTc-IDA-D-[c(RGDfK)]2 |
| Q34140326 | Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in canine simple mammary gland adenocarcinomas |
| Q46288581 | Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. |
| Q33690239 | Increased plasma YKL-40/chitinase-3-like-protein-1 is associated with endothelial dysfunction in obstructive sleep apnea |
| Q41692367 | Inhibition of VEGF: a novel mechanism to control angiogenesis by Withania somnifera's key metabolite Withaferin A. |
| Q35097368 | Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy. |
| Q28573499 | Insulin activates hypoxia-inducible factor-1alpha in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways: impairment in insulin resistance owing to defects in insulin signalling |
| Q24306665 | Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance |
| Q40230314 | Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis |
| Q28081000 | Intravitreal Anti-VEGF Injections in Pregnancy: Case Series and Review of Literature |
| Q37135388 | Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy |
| Q37243894 | Invited review: activity-induced angiogenesis |
| Q46833770 | Involvement of the Rho/Rho kinase signaling pathway in platelet-derived growth factor BB-induced vascular endothelial growth factor expression in diabetic rat retina |
| Q51992598 | Kidney development and gene expression in the HIF2alpha knockout mouse. |
| Q44647559 | Localization of vascular endothelial growth factor in the zona pellucida of developing ovarian follicles in the rat: a possible role in destiny of follicles |
| Q65000120 | Long-term progression-free survival of apatinib monotherapy for relapsed ovarian cancer: a case report and literature review. |
| Q28508637 | Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice |
| Q36057462 | MMPs and angiogenesis affect the metastatic potential of a human vulvar leiomyosarcoma cell line |
| Q33402889 | Management of diabetic retinopathy: could lipid-lowering be a worthwhile treatment modality? |
| Q35151099 | Mechanism and its regulation of tumor-induced angiogenesis |
| Q24629891 | Mechanisms of acetaminophen-induced liver necrosis |
| Q42173250 | Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension. |
| Q41701922 | MicroRNA-126 inhibits cell viability and invasion in a diabetic retinopathy model via targeting IRS-1. |
| Q28115714 | MicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 |
| Q37118124 | MicroRNAs as pharmacological targets in endothelial cell function and dysfunction |
| Q52652318 | MicroRNAs in endothelial cell homeostasis and vascular disease. |
| Q36198788 | Microsecond-pulsed dielectric barrier discharge plasma stimulation of tissue macrophages for treatment of peripheral vascular disease |
| Q34492816 | Microvascular angiogenesis and the renin-angiotensin system. |
| Q40237687 | Modulation of VEGF/Flk-1 receptor expression in the rat pituitary GH3 cell line by growth factors |
| Q91743400 | Molecular Responses in THP-1 Macrophage-Like Cells Exposed to Diverse Nanoparticles |
| Q30481645 | Molecular imaging of vessels in mouse models of disease |
| Q34710547 | Molecular mechanisms of lymphangiogenesis in health and disease |
| Q34803109 | Molecular medicine for the cardiac surgeon |
| Q35747435 | Molecular profiling of angiogenesis markers. |
| Q35747405 | Molecular profiling of angiogenic markers: a step towards interpretive analysis of a complex biological function |
| Q44644595 | Monitoring of circulating angiogenic factors in dendritic cell-based cancer immunotherapy. |
| Q33650481 | Multifunctional and biomimetic fish collagen/bioactive glass nanofibers: fabrication, antibacterial activity and inducing skin regeneration in vitro and in vivo |
| Q38631308 | N-glycoproteomic analysis of human follicular fluid during natural and stimulated cycles in patients undergoing in vitro fertilization |
| Q36413901 | Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers |
| Q33566770 | Nerve growth factor induces cord formation of mesenchymal stem cell by promoting proliferation and activating the PI3K/Akt signaling pathway |
| Q37315726 | Nerve growth factor induces vascular endothelial growth factor expression in granulosa cells via a trkA receptor/mitogen-activated protein kinase-extracellularly regulated kinase 2-dependent pathway |
| Q38297494 | Neurophilin-1 is a downstream target of transcription factor Ets-1 in human umbilical vein endothelial cells |
| Q28585676 | Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development |
| Q35788662 | Neuropilin-1 participates in wound angiogenesis |
| Q41829449 | Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity. |
| Q46266793 | Nonclinical safety evaluation of sunitinib: a potent inhibitor of VEGF, PDGF, KIT, FLT3, and RET receptors |
| Q33689928 | Notch regulates the angiogenic response via induction of VEGFR-1. |
| Q37681157 | Novel aspects of corneal angiogenic and lymphangiogenic privilege. |
| Q56883662 | Ontogeny of semaphorins 3A and 3F and their receptors neuropilins 1 and 2 in the kidney |
| Q33705041 | Pharmacological activation of PPARbeta promotes rapid and calcineurin-dependent fiber remodeling and angiogenesis in mouse skeletal muscle |
| Q33233477 | Phosphorylated KDR can be located in the nucleus of neoplastic cells |
| Q42323711 | Plasma VEGF levels in breast cancer patients with and without metastases |
| Q38974204 | Platelet-Derived Growth Factor (PDGF)/PDGF Receptors (PDGFR) Axis as Target for Antitumor and Antiangiogenic Therapy. |
| Q42668157 | Platelet-derived growth factors induced lymphangiogenesis: evidence, unanswered questions and upcoming challenges. |
| Q37728387 | Polymorphisms of VEGFA gene and susceptibility to hemorrhage risk of brain arteriovenous malformations in a Chinese population. |
| Q36682230 | Potent 19-norvitamin D analogs for prostate and liver cancer therapy |
| Q39429469 | Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review |
| Q46721436 | Preclinical safety evaluation of IFNalpha2a-NGR. |
| Q34635295 | Preeclampsia, an implantation disorder |
| Q34973747 | Principals of neovascularization for tissue engineering |
| Q24337272 | Programmed cell death 6 (PDCD6) inhibits angiogenesis through PI3K/mTOR/p70S6K pathway by interacting of VEGFR-2 |
| Q36032180 | Prokaryotic Soluble Overexpression and Purification of Human VEGF165 by Fusion to a Maltose Binding Protein Tag |
| Q37513161 | Prostate angiogenesis in development and inflammation |
| Q47593246 | Quantification of angiogenesis by functional computed tomography in a Matrigel model in rats |
| Q59811806 | Reactive Oxygen Species, Biomarkers of Microvascular Maturation and Alveolarization, and Antioxidants in Oxidative Lung Injury |
| Q36016325 | Receptor tyrosine kinase inhibitors AG013764 and AG013711 reduce choroidal neovascularization in rat eye. |
| Q42577163 | Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP. |
| Q27639165 | Refinement of the solution structure of the heparin-binding domain of vascular endothelial growth factor using residual dipolar couplings |
| Q39946802 | Regulation of hypoxia-induced angiogenesis: a chaperone escorts VEGF to the dance |
| Q34774011 | Regulation of microvascular permeability by vascular endothelial growth factors |
| Q38131857 | Regulation of placental angiogenesis |
| Q35127972 | Regulation of vascular permeability by vascular endothelial growth factors. |
| Q44881999 | Regulatory molecules for coronary expressions of VEGF and its angiogenic receptor KDR in hypoestrogenic middle-aged female rats |
| Q98290104 | Relationship between Serum Vascular Endothelial Growth Factor Levels and Stages of Diabetic Retinopathy and Other Biomarkers |
| Q44921129 | Renal vascular endothelial growth factor in neonatal obstructive nephropathy. II. Exogenous VEGF. |
| Q35791973 | Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin |
| Q47324792 | Retrospective analysis of the effect of aflibercept loading dose on the retinal vessel diameters in patients with treatment-naive neovascular AMD. |
| Q34136366 | Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. |
| Q38855635 | Reversibility of endothelial dysfunction in diabetes: role of polyphenols |
| Q24304277 | Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 |
| Q38322290 | Role of Raf kinase inhibitor protein in Helicobacter pylori-mediated signaling in gastric cancer |
| Q35181953 | Role of VEGF in kidney development, microvascular maintenance and pathophysiology of renal disease |
| Q81232141 | Role of elongin-binding domain of von Hippel Lindau gene product on HuR-mediated VPF/VEGF mRNA stability in renal cell carcinoma |
| Q83960085 | Role of peroxisome proliferator-activated receptor-alpha in acute pancreatitis induced by cerulein |
| Q26777855 | Role of platelet-rich plasma in ischemic heart disease: An update on the latest evidence |
| Q35726863 | Role of the novel HSP90 inhibitor AUY922 in hepatocellular carcinoma: Potential for therapy |
| Q77969624 | Roles of bradykinin in vascular permeability and angiogenesis in solid tumor |
| Q45911403 | S100B-RAGE dependent VEGF secretion by cardiac myocytes induces myofibroblast proliferation. |
| Q92886189 | Scaffold vascularization method using an adipose-derived stem cell (ASC)-seeded scaffold prefabricated with a flow-through pedicle |
| Q35829083 | Selective adapter recruitment and differential signaling networks by VEGF vs. shear stress |
| Q90574640 | Serum Vascular Endothelial Growth Factor Levels in the IVAN Trial; Relationships with Drug, Dosing, and Systemic Serious Adverse Events |
| Q41593771 | Shear stress-induced angiogenesis in mouse muscle is independent of the vasodilator mechanism and quickly reversible. |
| Q39752032 | Signaling required for blood vessel maintenance: molecular basis and pathological manifestations |
| Q35140893 | Significance of endothelial cell survival programs for renal transplantation |
| Q54578853 | Significance of heparanase-1 and vascular endothelial growth factor in adrenocortical carcinoma angiogenesis: potential for therapy. |
| Q35954103 | Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer |
| Q42358426 | Silver nanoparticles administered to chicken affect VEGFA and FGF2 gene expression in breast muscle and heart |
| Q30840204 | Single-chain vascular endothelial growth factor variant with antagonist activity |
| Q26749011 | Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects |
| Q38018123 | Splicing in oncogenesis and tumor suppression |
| Q36124029 | Stability and Species Specificity of Renal VEGF-A Splicing Patterns in Kidney Disease. |
| Q42151285 | Stress fracture healing: fatigue loading of the rat ulna induces upregulation in expression of osteogenic and angiogenic genes that mimic the intramembranous portion of fracture repair |
| Q35550649 | Structural, Functional, and Molecular MR Imaging of the Microvasculature |
| Q40334510 | Structure-activity relationships of the human prothrombin kringle-2 peptide derivative NSA9: anti-proliferative activity and cellular internalization |
| Q33787955 | Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis) |
| Q34731225 | Suitability of the rat subdermal model for tissue engineering of heart valves |
| Q92589100 | Synergistic Anti-Angiogenic Effects Using Peptide-Based Combinatorial Delivery of siRNAs Targeting VEGFA, VEGFR1, and Endoglin Genes |
| Q34544599 | Synthesized multiple antigenic polypeptide vaccine based on B-cell epitopes of human heparanase could elicit a potent antimetastatic effect on human hepatocellular carcinoma in vivo |
| Q33205837 | Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition |
| Q35067111 | Systemic medical management of diabetic retinopathy |
| Q36198145 | Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way. |
| Q37771243 | Targeted therapies in the management of colorectal carcinoma: role of bevacizumab. |
| Q31007381 | Targeting angiogenesis: structural characterization and biological properties of a de novo engineered VEGF mimicking peptide |
| Q47347013 | Temporal and spatial regulation of VEGF-A controls vascular patterning in the embryonic lung |
| Q27030833 | The Role of Hypoxia-Inducible Factor in Wound Healing |
| Q34104098 | The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1α expression |
| Q35832019 | The aortic ring model of angiogenesis: a quarter century of search and discovery |
| Q26823178 | The associations between VEGF gene polymorphisms and diabetic retinopathy susceptibility: a meta-analysis of 11 case-control studies |
| Q57243036 | The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes |
| Q24302171 | The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1 |
| Q50778384 | The determination of VEGF and MVD, among patients with primary breast cancer. |
| Q37130558 | The function of VEGF-A in lens development: formation of the hyaloid capillary network and protection against transient nuclear cataracts. |
| Q53381128 | The multi-kinase inhibitor pazopanib targets hepatic stellate cell activation and apoptosis alleviating progression of liver fibrosis. |
| Q37380374 | The pathologic continuum of diabetic vascular disease |
| Q48521375 | The presence of VEGF and Notch2 during preantral-antral follicular transition in infantile rats: Anatomical evidence and its implications. |
| Q46468770 | The role of vascular endothelial growth factor in wound healing |
| Q93357075 | Therapeutic effects of a liquid bandage prepared with cellulose powders from Styela clava tunics and Broussonetia kazinoki bark: Healing of surgical wounds on the skin of Sprague Dawley rats |
| Q35083219 | Therapeutic effects of fenofibrate on diabetic peripheral neuropathy by improving endothelial and neural survival in db/db mice |
| Q34104095 | Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenografts |
| Q42548913 | Time-dependent changes of plasma concentrations of angiopoietins, vascular endothelial growth factor, and soluble forms of their receptors in nonsmall cell lung cancer patients following surgical resection |
| Q37244781 | Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study. |
| Q52546968 | Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. |
| Q90194802 | Trends and Challenges in Tumor Anti-Angiogenic Therapies |
| Q36541140 | VEGF T-1498C polymorphism, a predictive marker of differentiation of colorectal adenocarcinomas in Japanese |
| Q34980825 | VEGF attenuates development from cardiac hypertrophy to heart failure after aortic stenosis through mitochondrial mediated apoptosis and cardiomyocyte proliferation |
| Q48358455 | VEGF expression is developmentally regulated during human brain angiogenesis |
| Q46965926 | VEGF immunopositivity related to malignancy degree, proliferative activity and angiogenesis in ENU-induced gliomas |
| Q24293027 | VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex |
| Q45863485 | VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death |
| Q35635564 | VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases |
| Q39249401 | VEGF receptor antagonist Cyclo-VEGI reduces inflammatory reactivity and vascular leakiness and is neuroprotective against acute excitotoxic striatal insult |
| Q41139771 | VEGF-C alters barrier function of cultured lymphatic endothelial cells through a VEGFR-3-dependent mechanism |
| Q42915525 | VEGF-PLCgamma1 pathway controls cardiac contractility in the embryonic heart |
| Q36573377 | VEGF-targeting therapy for breast cancer |
| Q30724216 | VEGF165 antisense RNA suppresses oncogenic properties of human esophageal squamous cell carcinoma |
| Q24302846 | VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection |
| Q53654605 | VEGFR2-targeted molecular imaging in the mouse embryo: an alternative to the tumor model. |
| Q37071626 | Variation of pathways and network profiles reveals the differential pharmacological mechanisms of each effective component to treat middle cerebral artery ischemia-reperfusion mice |
| Q55021686 | Vascular Endothelial Growth Factor Gene Polymorphism Is Associated With Long-term Kidney Allograft Outcomes. |
| Q28567645 | Vascular endothelial growth factor (VEGF) receptor-2 signaling mediates VEGF-C(deltaNdeltaC)- and VEGF-A-induced angiogenesis in vitro |
| Q34280300 | Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. |
| Q64328654 | Vascular endothelial growth factor and soluble vascular endothelial growth factor receptor-1 in patients with end-stage renal disease. Associations with laboratory findings, comorbidities, and medications |
| Q89755580 | Vascular endothelial growth factor concentration in vitreous humor of patients with severe proliferative diabetic retinopathy after intravitreal injection of conbercept as an adjunctive therapy for vitrectomy |
| Q36929380 | Vascular endothelial growth factor in eye disease |
| Q35045371 | Vascular endothelial growth factor increases heme oxygenase-1 protein expression in the chick embryo chorioallantoic membrane |
| Q37345998 | Vascular endothelial growth factor-A signaling in bone marrow-derived endothelial progenitor cells exposed to hypoxic stress |
| Q34249810 | Vascular endothelial growth factor: molecular underpinning from development of vasculature to development of disease |
| Q58788212 | Visualizing Ligand Binding to a GPCR In Vivo Using NanoBRET |
| Q37761659 | Visualizing vascular permeability and lymphatic drainage using labeled serum albumin |
| Q48747309 | [Analysis of cardiovascular diseases after the upload phase with intravitreal ranibizumab and bevacizumab in patients with exudative age-related macular degeneration]. |
| Q36544702 | sMEK1 inhibits endothelial cell proliferation by attenuating VEGFR-2-dependent-Akt/eNOS/HIF-1α signaling pathways |
Search more.